文献速递胸部技术与安全CT

基线筛查阴性后年度重复肺癌筛查的依从性及自付费用影响

Repeat Annual Lung Cancer Screening After Baseline Screening Among Screen-Negative Individuals: No-Cost Coverage Is Not Enough.
PubMed 文献 · J Am Coll Radiol · 2022-11-25

该研究基于美国商业保险理赔数据,纳入14,943例基线低剂量CT肺癌筛查阴性个体,发现仅30.5%在10-15个月后接受重复年度筛查。男性、西班牙裔、赔偿型保险计划及较高年度自付费用与重复筛查可能性降低独立相关。

要点

  • 基线筛查阴性后仅30.5%个体按时重复年度肺癌筛查,依从性亟待提高。
  • 年度自付费用最高两个四分位者重复筛查可能性显著降低(aOR 0.85和0.75)。
  • 男性、西班牙裔及赔偿型保险计划者重复筛查可能性更低。

局限性

  • 仅纳入商业保险雇主投保人群,结论外推至其他保险类型或未保险人群受限。
  • 回顾性理赔数据分析,可能存在未测量的混杂因素。
  • 筛查阴性定义及重复筛查时间窗基于理赔编码,可能存在错分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Adherence to lung cancer screening (LCS) is central to effective screening. The authors evaluated the likelihood of repeat annual LCS in a national commercially insured population and associations with individual characteristics, insurance characteristics, and annual out-of-pocket cost (OOPC) burden.

METHODS: Using claims data from an employer-insured population (Clinformatics), individuals 55 to 80 years of age undergoing LCS between January 1, 2015, to September 30, 2019, with "negative" LCS were included. Repeat LCS was defined as low-dose chest CT occurring 10 to 15 months after the preceding LCS. Analysis was conducted over a 6-year period. Multivariable logistic regression was used to evaluate associations between repeat LCS and individual characteristics, insurance characteristics, and total OOPC incurred by the individual in the year of the index LCS, even if unrelated to LCS.

RESULTS: Of 14,943 individuals with negative LCS, 4,561 (30.5%) underwent repeat LCS. Likelihood of repeat LCS was decreased for men (adjusted odds ratio [aOR], 0.91; 95% confidence interval [CI], 0.86-0.97), Hispanic ethnicity (aOR, 0.82; 95% CI, 0.69-0.97), and indemnity insurance plans (aOR, 0.36; 95% CI, 0.25-0.53). Relative to New England, individuals in nearly all US geographic regions were less likely to undergo repeat LCS. Finally, individuals with total OOPC in the highest two quartiles were less likely to undergo repeat LCS (aOR, 0.85 [95% CI, 0.77-0.92] for OOPC >$1,069.02-$2,475.09 vs $0-$351.82; aOR, 0.75 [95% CI, 0.68-0.82] for OOPC >$2,475.09 vs $0-$351.82).

CONCLUSIONS: Although federal policies facilitate LCS without cost sharing, individuals incurring high OOPC, even when unrelated to LCS, are less likely to undergo repeat LCS. Future policy design should consider the permeative burden of OOPC across the health continuum on preventive services use.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Tailor, Bell, Doo, et al. Repeat Annual Lung Cancer Screening After Baseline Screening Among Screen-Negative Individuals: No-Cost Coverage Is Not Enough. J Am Coll Radiol. 2022. PMID: 36436778. doi:10.1016/j.jacr.2022.11.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。